Core Laboratories Inc. Form 8-K Summary
Business Context and Reporting Period
Core Laboratories Inc. filed a Form 8-K dated March 21, 2024, under Item 5.02 regarding a change in the Company’s principal accounting officer. The report was signed on March 25, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes
- Kevin Daniels announced his resignation as Vice President and Chief Accounting Officer to pursue other opportunities.
- The Company stated that Mr. Daniels’s departure was not due to any dispute or disagreement concerning the Company’s accounting practices or financial statements.
- Effective March 21, 2024, the Board appointed Sow Hang Teo as Vice President and Chief Accounting Officer.
- Mr. Teo had served as Corporate Controller of Financial Reporting since September 2017 and has held several other finance and accounting roles at the Company since joining in February 2006.
Outlook, Risks, and Unusual Items
The filing provides no financial guidance or outlook. The accounting officer transition may warrant monitoring for continuity of financial reporting and internal controls, although the filing identifies no accounting dispute or disagreement.
Mr. Teo is a certified public accountant and chartered accountant. The filing states that there are no transactions between Mr. Teo and the Company requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Items
- Confirm the effective date and scope of Mr. Teo’s responsibilities as Chief Accounting Officer.
- Review subsequent filings for any changes in financial reporting personnel, internal controls, accounting policies, or reported results.
- Verify whether future filings disclose any transition-related effects or additional information regarding Mr. Daniels’s departure.